Attorney General Todd Rokita announces Indiana government will receive $154,000 from generic drug manufacturer and individual Hoosiers could be owed money
Multistate coalition achieved $29.6 million national settlement to resolve allegations that Glenmark Pharmaceuticals conspired to inflate prices and limit competition
Attorney General Todd Rokita today announced a settlement with Glenmark Pharmaceuticals, a generic drug manufacturer that allegedly conspired to inflate prices and limit competition, will bring Indiana $154,000.
“We continue holding Big Pharma accountable when they harm Hoosiers by putting profits over people,” Attorney General Rokita said. “These companies must be made to honor their ethical and legal obligations to consumers.”
If you bought certain generic prescription drugs in the United States between May 1, 2009, and December 31, 2019, you could be eligible for money. To find out, call 1-866-290-0182, email info@AGGenericDrugs.com or visit www.AGGenericDrugs.com.
Indiana is part of a coalition of 48 states and territories entering into a $29.6 million settlement with Glenmark. As part of the settlement agreement, Glenmark has agreed to comply with antitrust laws and implement internal reforms to bring about fair competition.
